• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Immunomedics Inc

+ Add to Watchlist

IM3:GR

3.411 EUR 0.124 3.77%

As of 11:55:17 ET on 11/28/2014.

Snapshot for Immunomedics Inc (IM3)

Open: 3.289 Day's Range: 3.288 - 3.452 Volume: 0
Previous Close: 3.287 52wk Range: 2.189 - 4.494 1-Yr Rtn: +9.19%

Stock Chart for IM3

No chart data available.
  • IM3:GR 3.288
  • 1D
  • 1M
  • 1Y
3.287
Interactive IM3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IM3

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) -0.5100
Est. PEG Ratio -
Market Cap (M EUR) 317.68
Shares Outstanding (M) 93.13
30 Day Average Volume 323
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0010
Dividend Ex-Date 03/15/2002
5 Year Dividend Growth -
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IM3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IM3

Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.

David M GoldenbergChairman/Chief Scientific OfcrCynthia L SullivanPresident/CEO
Peter P PfreundschuhVP:Finance/CFOChau ChengSenior Dir:Investor Relations
More Company Profile & Key Executives for IM3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil